Related Experiment Video
Updated: Jul 26, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study
F Zulian1, B H Athreya, R Laxer
1Dipartimento di Pediatria, Università di Padova, Via Giustiniani 3, 35128 Padova, Italy. zulian@pediatria.unipd.it
Insights
Juvenile localized scleroderma (JLS) is a complex group of conditions. This large study details its subtypes, triggers, and immunological markers, aiding in developing better classification criteria for pediatric rheumatology and dermatology.
Area of Science:
- Pediatric rheumatology
- Pediatric dermatology
- Autoimmune diseases
Background:
- Juvenile localized scleroderma (JLS) encompasses diverse conditions lacking uniform classification.
- Understanding JLS epidemiology and clinical presentation is crucial for developing diagnostic criteria.
Purpose of the Study:
- To investigate the epidemiological, clinical, and immunological features of JLS in children.
- To gather data for the long-term goal of establishing uniform classification criteria for JLS.
Main Methods:
- A large, multicenter, multinational study involving 750 pediatric patients with JLS from 70 centers.
- Data collection included demographics, family history, environmental triggers, clinical and laboratory findings, and treatments.
Main Results:
- Linear scleroderma (65%) was the most common JLS subtype, with 15% presenting with mixed subtypes.
- Positive antinuclear antibodies (ANA) were observed in 42.3% of patients.
- Methotrexate was the most frequently utilized treatment, particularly in recent years.
Conclusions:
- This study is the largest reported collection of JLS patients, highlighting diagnostic delays and varied presentations.
- Recognizing mixed and other subtypes is essential for improving JLS classification.
- Findings will inform educational efforts and contribute to a comprehensive JLS classification system.
Objective:
Juvenile localized scleroderma (JLS) includes a number of conditions often grouped together. With the long-term goal of developing uniform classification criteria, we studied the epidemiological, clinical and immunological features of children with JLS followed by paediatric rheumatology and dermatology centres.
Methods:
A large, multicentre, multinational study was conducted by collecting information on the demographics, family history, triggering environmental factors, clinical and laboratory features, and treatment of patients with JLS.
Results:
Seven hundred and fifty patients with JLS from 70 centres were enrolled into the study. The disease duration at diagnosis was 18 months. Linear scleroderma (LS) was the most frequent subtype (65%), followed by plaque morphea (PM) (26%), generalized morphea (GM) (7%) and deep morphea (DM) (2%). As many as 15% of patients had a mixed subtype. Ninety-one patients (12%) had a positive family history for rheumatic or autoimmune diseases; 100 (13.3%) reported environmental events as possible trigger. ANA was positive in 42.3% of the patients, with a higher prevalence in the LS-DM subtype than in the PM-GM subtype. Scl70 was detected in the sera of 3% of the patients, anticentromere antibody in 2%, anti-double-stranded DNA in 4%, anti-cardiolipin antibody in 13% and rheumatoid factor in 16%. Methotrexate was the drug most frequently used, especially during the last 5 yr.
Conclusion:
This study represents the largest collection of patients with JLS ever reported. The insidious onset of the disease, the delay in diagnosis, the recognition of mixed subtype and the better definition of the other subtypes should influence our efforts in educating trainees and practitioners and help in developing a comprehensive classification system for this syndrome.
Related Concept Videos
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

